NIAID is committed to making sure that NIAID-supported discoveries move steadily from the laboratory toward development into products such as approved vaccines, treatments, or diagnostic tools that improve public health. The project development trajectory can be long. The NIAID Office of Technology Development (OTD) pursues collaborations with industry, academia, non-profit organizations, and other government agencies to ease exchange of research information and materials and to facilitate the translation of research findings, technologies, and materials into useful products.
Collaborative ventures are supported by various agreements, including cooperative research and development agreements (CRADAs) and research collaboration agreements (RCAs). These partnerships leverage NIAID resources to develop
Learn more about technology development at NIAID:
Last Updated November 17, 2011
Last Reviewed August 03, 2011